p53 is frequently mutated in Barrett's metaplasia of the intestinal type

被引:0
|
作者
Campomenosi, P
Conio, M
Bogliolo, M
Urbini, S
Assereto, P
Aprile, A
Monti, P
Aste, H
Lapertosa, G
Inga, A
Abbondandolo, A
Fronza, G
机构
[1] IST NAZL RIC CANC,CTR STUDY TUMORS,ENVIRONM ORIGINS MUTAGENESIS LAB,I-16132 GENOA,ITALY
[2] IST NAZL RIC CANC,GASTROENTEROL UNIT,I-16132 GENOA,ITALY
[3] UNIV GENOA,CHAIR ANAT PATHOL,GENOA,ITALY
[4] UNIV GENOA,CHAIR GENET,GENOA,ITALY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Barrett's Esophagus (BE) is a complication of gastroesophageal reflux in which the normal squamous epithelium of the lower esophagus is replaced by metaplastic tissue. The clinical significance of this condition is the associated predisposition to adenocarcinomas (ADCs). Three types of BE have been characterized: the gastric fundic (F) type, the gastric cardial (C) type, and the intestinal (I) type. The latter is the most closely associated with the development of ADCs; the causes of this bias remain unknown. To determine whether p53 and/or K-ms gene alterations (a) are present in preneoplastic lesions and (b) are associated with a specific histotype, we performed PCR-based denaturing gradient gel electrophoresis (DGGE) analysis of exon 1 (codons 12-13) of K-ms gene and of exons 5-8 of the p53 gene in biopsies obtained from 30 patients with BE of the I type (9 patients), combined I type (I + C +/- F; 10 patients) and non-I type (C, F, or C + F; 11 patients). None of the cases under study revealed K-ras mutations, whereas biopsies from 12 patients showed at least one p53 DGGE variant. Four patients showed the exact same variants in leukocytes also (polymorphisms), whereas eight cases revealed specific DGGE variants only in biopsies. The molecular characterization of these variants revealed that four of them showed a single base pair substitution, and four showed multiple mutations. Of 17 somatic mutations, all but 1 were base pair substitutions located mainly in exons 7 and 8. The majority of these mutations were GC targeted (13 of 16; 81%), 54% (7 of 13) of which were transitions occurring at CpG sites. All somatic mutations were found in BE with at least one I component. The association with the histotype was statistically significant (P < 0.03; pure I type versus non-I type; P < 0.04, combined I type versus non-I type; Fisher's exact test). Loss of heterozygosity in the vicinity of the p53 locus was evaluated by PCR using a highly polymorphic variable number of tandem repeats marker on 25 out of 30 cases. Ninety-two % of the cases analyzed were informative, and none of them showed LOH. In conclusion, we showed that p53 mutations are frequently observed in specimens from BE patients of the I-type, whereas no involvement of K-ras (exon 1) mutational activation was observed. In light of the key roles that the p53 protein plays in controlling cell cycle and cell diploidy, this result may suggest why this type of metaplasia is the most closely associated to the development of ADCs.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 50 条
  • [41] Acid suppression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation
    Carlson, N
    Lechago, J
    Richter, J
    Sampliner, RE
    Peterson, L
    Santella, RM
    Goldblum, JR
    Falk, GW
    Ertan, A
    Younes, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (06): : 1340 - 1345
  • [42] The role of p53 assessment in the management of Barrett's oesophagus
    Kubba, AK
    Poole, NA
    Watson, A
    GUT, 1999, 44 : A107 - A107
  • [43] Role of p53 assessment in management of Barrett's esophagus
    Kubba, AK
    Poole, NA
    Watson, A
    DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (04) : 659 - 667
  • [44] Role of p53 Assessment in Management of Barrett's Esophagus
    A. K. Kubba
    N. A. Poole
    A. Watson
    Digestive Diseases and Sciences, 1999, 44 : 659 - 667
  • [45] Barrett's esophagus - The significance of p53 in clinical practice
    Ireland, AP
    Clark, GWB
    DeMeester, TR
    ANNALS OF SURGERY, 1997, 225 (01) : 17 - 30
  • [46] Role of p53 in the inhibition of proliferation of gastric cancer cells expressing wild-type or mutated p53
    Ji, Wansheng
    Ma, Jingrong
    Zhang, Hongmei
    Zhong, Hua
    Li, Lei
    Ding, Na
    Jiao, Jianxin
    Gao, Zhixing
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 691 - 695
  • [47] The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia
    Szoke, D.
    Molnar, B.
    Solymosi, N.
    Sipos, F.
    Galamb, O.
    Gyorffy, A.
    Tulassay, Z.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (03) : 179 - 184
  • [48] p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett's oesophagus
    Lian, Guodong
    Malagola, Ermanno
    Wei, Chengguo
    Shi, Qiongyu
    Zhao, Junfei
    Hata, Masahiro
    Kobayashi, Hiroki
    Ochiai, Yosuke
    Zheng, Biyun
    Zhi, Xiaofei
    Wu, Feijing
    Tu, Ruhong
    Napoles, Osmel Companioni
    Su, Wenjing
    Li, Leping
    Jing, Changqing
    Chen, Man
    Zamechek, Leah
    Friedman, Richard
    Nowicki-Osuch, Karol
    Quante, Michael
    Que, Jianwen
    Wang, Timothy C.
    GUT, 2024,
  • [49] Topography of Intestinal Metaplasia and Dysplasia in Barrett's Esophagus
    Januszewicz, Wladyslaw
    Bielasik, Andrzej
    Orlowska, Janina
    Nasierowska-Guttmejer, Anna
    Regula, Jaroslaw
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB193 - AB194
  • [50] Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia
    Rugge, Massimo
    Fassan, Matteo
    Battaglia, Giorgio
    Parente, Paola
    Zaninotto, Giovanni
    Ancona, Ermanno
    HUMAN PATHOLOGY, 2009, 40 (08) : 1206 - 1207